{"id":16543,"date":"2025-01-17T15:04:44","date_gmt":"2025-01-17T15:04:44","guid":{"rendered":"https:\/\/www.info-welt.com\/en\/index.php\/2025\/01\/17\/understanding-myelofibrosis-symptoms-and-treatment-options\/"},"modified":"2025-01-17T15:04:44","modified_gmt":"2025-01-17T15:04:44","slug":"understanding-myelofibrosis-symptoms-and-treatment-options","status":"publish","type":"post","link":"https:\/\/www.info-welt.com\/en\/index.php\/2025\/01\/17\/understanding-myelofibrosis-symptoms-and-treatment-options\/","title":{"rendered":"Understanding Myelofibrosis: Symptoms and Treatment Options"},"content":{"rendered":"<p><b>Myelofibrosis<\/b> is a rare <b>blood disorder<\/b> that affects healthy blood cell production. This <b>chronic leukemia<\/b> scars bone marrow, causing serious health issues<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.jakafi.com\/pdf\/understanding-myelofibrosis.pdf\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">1<\/a><\/sup>. About 16,000 to 18,500 people in the U.S. live with this condition<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.jakafi.com\/pdf\/understanding-myelofibrosis.pdf\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">1<\/a><\/sup>.<\/p>\n<p>The disease usually strikes around age 65, but can affect younger people<sup class=\\\"citation\\\"><a href=\\\"https:\/\/mpnresearchfoundation.org\/primary-myelofibrosis-pmf\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">2<\/a><\/sup>. Genes play a big role in <b>myelofibrosis<\/b>. Half to 60% of patients have a JAK2 gene mutation<sup class=\\\"citation\\\"><a href=\\\"https:\/\/mpnresearchfoundation.org\/primary-myelofibrosis-pmf\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">2<\/a><\/sup>.<\/p>\n<p>About 23.5% of patients have a Calreticulin (CALR) mutation<sup class=\\\"citation\\\"><a href=\\\"https:\/\/mpnresearchfoundation.org\/primary-myelofibrosis-pmf\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">2<\/a><\/sup>. Knowing your specific condition helps manage this <b>bone marrow disease<\/b> better. Treatment depends on symptom severity and genetic profile.<\/p>\n<p>Medications like Jakafi (ruxolitinib) help patients with intermediate or high-risk <b>myelofibrosis<\/b><sup class=\\\"citation\\\"><a href=\\\"https:\/\/mpnresearchfoundation.org\/primary-myelofibrosis-pmf\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">2<\/a><\/sup>. These drugs aim to improve <b>quality of life<\/b> and manage symptoms effectively.<\/p>\n<h3>Key Takeaways<\/h3>\n<ul>\n<li>Myelofibrosis is a rare <b>blood disorder<\/b> affecting bone marrow function<\/li>\n<li>Genetic mutations play a significant role in disease development<\/li>\n<li>Most patients are diagnosed around age 65<\/li>\n<li>Treatment focuses on managing symptoms and improving <b>quality of life<\/b><\/li>\n<li>Multiple medication options are available for different risk levels<\/li>\n<\/ul>\n<h2>What is Myelofibrosis and Its Impact on Your Body<\/h2>\n<p>Myelofibrosis is a rare bone marrow disorder that affects blood cell production. It occurs when stem cells in your bone marrow develop genetic mutations<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.mayoclinic.org\/diseases-conditions\/myelofibrosis\/symptoms-causes\/syc-20355057\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">3<\/a><\/sup>. These changes alter how blood cells are created.<\/p>\n<p>Learning about these changes can help you understand the disease better. It can also shed light on potential treatment options.<\/p>\n<h3>Understanding Bone Marrow Changes<\/h3>\n<p>In myelofibrosis, healthy bone marrow turns into scarred, fibrous tissue. This change makes it hard to produce normal blood cells. Stem cell mutations cause abnormal cell growth.<\/p>\n<p>This leads to:<\/p>\n<ul>\n<li>Reduced red blood cell production (<b>anemia<\/b>)<\/li>\n<li>Excessive white blood cell generation<\/li>\n<li>Irregular platelet levels<\/li>\n<\/ul>\n<h3>Common Risk Factors and Causes<\/h3>\n<p>Myelofibrosis usually appears in people over 50 years old<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.cancerresearchuk.org\/about-cancer\/myelofibrosis\/what-is-myelofibrosis\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">4<\/a><\/sup>. Several factors can increase your risk:<\/p>\n<ol>\n<li>Chemical exposure (benzene, toluene)<\/li>\n<li>High radiation exposure<\/li>\n<li>Age-related genetic changes<\/li>\n<\/ol>\n<h3>Role of Genetic Mutations in Development<\/h3>\n<p>Genetic mutations are key in myelofibrosis development. The most common mutations involve specific genes:<\/p>\n<table>\n<tr>\n<th>Gene<\/th>\n<th>Mutation Frequency<\/th>\n<\/tr>\n<tr>\n<td>JAK2<\/td>\n<td>More than 55% of cases<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.cancerresearchuk.org\/about-cancer\/myelofibrosis\/what-is-myelofibrosis\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">4<\/a><\/sup><\/td>\n<\/tr>\n<tr>\n<td>CALR<\/td>\n<td>Up to 35% of cases<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.cancerresearchuk.org\/about-cancer\/myelofibrosis\/what-is-myelofibrosis\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">4<\/a><\/sup><\/td>\n<\/tr>\n<tr>\n<td>MPL<\/td>\n<td>About 8% of cases<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.cancerresearchuk.org\/about-cancer\/myelofibrosis\/what-is-myelofibrosis\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">4<\/a><\/sup><\/td>\n<\/tr>\n<\/table>\n<p>Some patients may not have identifiable gene mutations. <b>Stem cell transplant<\/b> is a possible treatment option for this complex condition.<\/p>\n<p>Your doctor can help choose the best approach using <b>JAK inhibitors<\/b>. They\\&#8217;ll consider your specific <b>cytogenetic abnormalities<\/b>.<\/p>\n<blockquote><p>Early detection and understanding of genetic mutations can significantly impact treatment strategies for myelofibrosis.<\/p><\/blockquote>\n<h2>Recognizing Common Symptoms and Complications<\/h2>\n<p>Myelofibrosis has many symptoms that can affect your daily life. The disease progresses slowly, often going unnoticed at first. Knowing these symptoms is key for early detection and management.<\/p>\n<p><div class=\"ast-oembed-container \" style=\"height: 100%;\"><iframe loading=\"lazy\" title=\"Myelofibrosis - causes, symptoms, diagnosis, treatment, pathology\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/Ft8Beh15osM?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/div>\n<\/p>\n<ul>\n<li><b>Splenomegaly<\/b> (enlarged spleen) causing pain or fullness below the left ribs<\/li>\n<li>Severe <b>anemia<\/b> leading to persistent fatigue and weakness<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.healthline.com\/health\/neurological-health\/myelofibrosis-complications\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">5<\/a><\/sup><\/li>\n<li><b>Thrombocytopenia<\/b> resulting in easy bruising and bleeding risks<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.healthline.com\/health\/neurological-health\/myelofibrosis-complications\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">5<\/a><\/sup><\/li>\n<li><b>Constitutional symptoms<\/b> like night sweats, fever, and unexplained weight loss<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.mappingmf.com\/charting-myelofibrosis\/what-is-myelofibrosis\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">6<\/a><\/sup><\/li>\n<\/ul>\n<p>Serious complications can include:<\/p>\n<ol>\n<li>Portal hypertension<\/li>\n<li>Increased risk of acute myeloid leukemia (15-20% of cases)<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.healthline.com\/health\/neurological-health\/myelofibrosis-complications\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">5<\/a><\/sup><\/li>\n<li>Extramedullary blood cell formation<\/li>\n<li>Bone and joint pain<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.healthline.com\/health\/neurological-health\/myelofibrosis-complications\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">5<\/a><\/sup><\/li>\n<\/ol>\n<blockquote><p>\\&#8221;Early recognition of symptoms is key to managing myelofibrosis effectively\\&#8221;<\/p><\/blockquote>\n<p>Doctors use blood tests and bone marrow biopsies to diagnose myelofibrosis<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.mappingmf.com\/charting-myelofibrosis\/what-is-myelofibrosis\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">6<\/a><\/sup>. In the USA, 3.6 to 5.7 per 100,000 people have this condition<sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3912063\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">7<\/a><\/sup>. Knowing the symptoms helps you get medical help quickly.<\/p>\n<p>New treatments like <b>JAK inhibitors<\/b> can reduce symptoms and improve life quality<sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3912063\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">7<\/a><\/sup>. Your doctor can create a treatment plan just for you<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.mappingmf.com\/charting-myelofibrosis\/what-is-myelofibrosis\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">6<\/a><\/sup>.<\/p>\n<h2>Conclusion<\/h2>\n<p><b>Myelofibrosis treatment<\/b> aims to enhance life quality through personalized medical approaches. The median survival ranges from 5-7 years. Innovative therapies offer increasing hope<sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3789453\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">8<\/a><\/sup>.<\/p>\n<p><b>JAK inhibitors<\/b> like Jakafi have transformed treatment options. They provide symptom relief and may extend patient survival<sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3789453\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">8<\/a><\/sup>. Genetic mutations are key in developing targeted treatments.<\/p>\n<p>About 50% of myelofibrosis patients have the JAK2V617F mutation. This helps doctors create precise intervention strategies<sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3789453\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">8<\/a><\/sup>. <a href=\\\"https:\/\/healthtree.org\/myelofibrosis\/community\/articles\/secondary-myelofibrosis\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">Advanced research<\/a> explores new therapies for specific genetic variations.<\/p>\n<p>Current treatments can\\&#8217;t cure the disease, but patients have options to manage symptoms. Hematopoietic stem cell transplantation is the only potentially curative treatment<sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3789453\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">8<\/a><\/sup>.<\/p>\n<p>Clinical trials and targeted JAK inhibitors offer new hope. They provide better ways to manage the condition. Your myelofibrosis journey is unique.<\/p>\n<p>Work closely with specialized healthcare professionals. They can help you navigate treatment challenges. Stay informed and explore all available options.<\/p>\n<section class=\\\"schema-section\\\">\n<h2>FAQ<\/h2>\n<div>\n<h3>What exactly is myelofibrosis?<\/h3>\n<div>\n<div>\n<p>Myelofibrosis is a rare blood cancer causing bone marrow scarring. It disrupts normal blood cell production. This <b>chronic leukemia<\/b> can be primary or develop from another bone marrow disorder.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>What causes myelofibrosis?<\/h3>\n<div>\n<div>\n<p>Myelofibrosis occurs when bone marrow stem cells have DNA mutations. These mutations lead to abnormal blood cell production.<\/p>\n<p>Risk factors include being over 50, exposure to chemicals like benzene, and radiation. Specific genetic mutations in JAK2, CALR, and MPL genes also play a role.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>What are the most common symptoms of myelofibrosis?<\/h3>\n<div>\n<div>\n<p>Common symptoms include fatigue, weakness, and shortness of breath. You might feel pain below your left ribs due to an enlarged spleen.<\/p>\n<p>Other signs are easy bruising, night sweats, fever, and bone pain. Some people experience weight loss, itching, and joint pain.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>How is myelofibrosis diagnosed?<\/h3>\n<div>\n<div>\n<p>Diagnosis involves medical exams, blood counts, and genetic testing. Doctors look for specific mutations and assess blood cell production.<\/p>\n<p>They also check spleen size and overall symptoms. Early stages may not show symptoms, so regular check-ups are crucial.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>What treatment options are available for myelofibrosis?<\/h3>\n<div>\n<div>\n<p>Treatment aims to manage symptoms and improve life quality. JAK inhibitors like Jakafi, Inrebic, and Vonjo can reduce spleen size.<\/p>\n<p>Stem cell transplantation is the only potential cure, but it\\&#8217;s risky. Other options include blood transfusions, corticosteroids, and targeted therapies.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>What complications can arise from myelofibrosis?<\/h3>\n<div>\n<div>\n<p>Complications may include portal hypertension and abdominal pain. Extramedullary hematopoiesis and bleeding issues due to low platelet counts can occur.<\/p>\n<p>There\\&#8217;s also an increased risk of developing acute myelogenous leukemia. Careful medical monitoring and personalized treatment strategies are essential.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>Is myelofibrosis curable?<\/h3>\n<div>\n<div>\n<p>Allogeneic stem cell transplantation is the only potential cure, but it\\&#8217;s risky. Most treatments focus on managing symptoms and improving life quality.<\/p>\n<p>Prognosis varies among patients. Some live many years with minimal symptoms, while others experience rapid progression.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<h2>Source Links<\/h2>\n<ol data-type=\\\"sources\\\">\n<li>PDF &#8211; <a href=\\\"https:\/\/www.jakafi.com\/pdf\/understanding-myelofibrosis.pdf\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.jakafi.com\/pdf\/understanding-myelofibrosis.pdf<\/a><\/li>\n<li>Myelofibrosis \u2013 MPN Research Foundation &#8211; <a href=\\\"https:\/\/mpnresearchfoundation.org\/primary-myelofibrosis-pmf\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/mpnresearchfoundation.org\/primary-myelofibrosis-pmf\/<\/a><\/li>\n<li>Myelofibrosis &#8211; Symptoms and causes &#8211; <a href=\\\"https:\/\/www.mayoclinic.org\/diseases-conditions\/myelofibrosis\/symptoms-causes\/syc-20355057\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.mayoclinic.org\/diseases-conditions\/myelofibrosis\/symptoms-causes\/syc-20355057<\/a><\/li>\n<li>What is myelofibrosis? &#8211; <a href=\\\"https:\/\/www.cancerresearchuk.org\/about-cancer\/myelofibrosis\/what-is-myelofibrosis\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.cancerresearchuk.org\/about-cancer\/myelofibrosis\/what-is-myelofibrosis<\/a><\/li>\n<li>Myelofibrosis Complications: Enlarged Spleen and More &#8211; <a href=\\\"https:\/\/www.healthline.com\/health\/neurological-health\/myelofibrosis-complications\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.healthline.com\/health\/neurological-health\/myelofibrosis-complications<\/a><\/li>\n<li>What is Myelofibrosis? &#8211; <a href=\\\"https:\/\/www.mappingmf.com\/charting-myelofibrosis\/what-is-myelofibrosis\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.mappingmf.com\/charting-myelofibrosis\/what-is-myelofibrosis\/<\/a><\/li>\n<li>Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes &#8211; <a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3912063\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3912063\/<\/a><\/li>\n<li>Advances in myelofibrosis: a clinical case approach &#8211; <a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3789453\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3789453\/<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Learn about myelofibrosis symptoms, diagnosis, and current treatment options. Discover how to manage this rare bone marrow disorder and improve your quality of life<\/p>\n","protected":false},"author":1,"featured_media":16545,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[5],"tags":[1123,1124,1125,1126,1127,1128,1129],"class_list":["post-16543","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-anemia","tag-blood-disorder","tag-bone-marrow-disease","tag-enlarged-spleen","tag-jak2-mutation","tag-myelofibrosis-symptoms","tag-myelofibrosis-treatment-options"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false},"uagb_author_info":{"display_name":"wpmanag984","author_link":"https:\/\/www.info-welt.com\/en\/author\/wpmanag984\/"},"uagb_comment_info":0,"uagb_excerpt":"Learn about myelofibrosis symptoms, diagnosis, and current treatment options. Discover how to manage this rare bone marrow disorder and improve your quality of life","_links":{"self":[{"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/posts\/16543","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/comments?post=16543"}],"version-history":[{"count":0,"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/posts\/16543\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/media?parent=16543"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/categories?post=16543"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/tags?post=16543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}